SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-052211
Filing Date
2020-11-09
Accepted
2020-11-09 08:00:06
Documents
47
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q wve-10q_20200930.htm   iXBRL 10-Q 1859979
2 EX-10.1 wve-ex101_100.htm EX-10.1 36526
3 EX-31.1 wve-ex311_9.htm EX-31.1 14712
4 EX-31.2 wve-ex312_10.htm EX-31.2 15042
5 EX-32 wve-ex32_7.htm EX-32 8875
6 GRAPHIC g15xibmjom2x000001.jpg GRAPHIC 47712
  Complete submission text file 0001564590-20-052211.txt   4409731

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA wve-20200930.xsd EX-101.SCH 30424
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE wve-20200930_cal.xml EX-101.CAL 34585
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE wve-20200930_def.xml EX-101.DEF 89832
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE wve-20200930_lab.xml EX-101.LAB 240595
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE wve-20200930_pre.xml EX-101.PRE 170561
12 EXTRACTED XBRL INSTANCE DOCUMENT wve-10q_20200930_htm.xml XML 339339
Mailing Address 733 CONCORD AVENUE CAMBRIDGE MA 02138
Business Address 7 STRAITS VIEW #12-00, MARINA ONE EAST TOWER SINGAPORE U0 018936 617-949-2900
Wave Life Sciences Ltd. (Filer) CIK: 0001631574 (see all company filings)

IRS No.: 000000000 | State of Incorp.: U0 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37627 | Film No.: 201296159
SIC: 2834 Pharmaceutical Preparations